What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients

被引:23
作者
Maremmani, Angelo G. I. [1 ,2 ,3 ]
Pacini, Matteo [3 ]
Maremmani, Icro [2 ,3 ,4 ]
机构
[1] North Western Tuscany Reg NHS Local Hlth Unit, Dept Psychiat, I-55049 Versilia Zone, Viareggio, Italy
[2] Assoc Applicat Neurosci Knowledge Social Aims AU, I-55045 Pietrasanta, Lucca, Italy
[3] G De Lisio Inst Behav Sci, I-56127 Pisa, Italy
[4] Univ Pisa, Santa Chiara Univ Hosp, VP Dole Dual Disorder Unit, Psychiat Unit 2, I-56126 Pisa, Italy
关键词
Dual Disorder; Heroin Use Disorder; Mood Disorders; Anxiety Disorders; Psychotic Disorders; Violence; Alcohol Use Disorder; Methadone Maintenance Treatment; ALCOHOL-DEPENDENT PATIENTS; COMORBID SUBSTANCE-ABUSE; LONG-TERM OUTCOMES; AGGRESSIVE-BEHAVIOR; BETA-ENDORPHIN; PERIAQUEDUCTAL GRAY; OPIATE ADDICTION; DOUBLE-BLIND; SCHIZOPHRENIC-PATIENTS; PSYCHIATRIC-DISORDERS;
D O I
10.3390/ijerph16030447
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Mental Disorders and Heroin Use Disorder (HUD) often co-occur and constitute correlated risk factors that the authors believe are best considered from a unitary perspective. In this article we review and discuss data collected by the V.P. Dole Research Group in Dual Disorder (V.P. Dole DD-RG) patients according to the following six discussion points: (1) Treatment of personality disorders during Methadone Maintenance Treatment (MMT); (2) Treatment of Mood Disorders during MMT; (3) Treatment of Anxiety Disorders during MMT; (4) Treatment of Psychotic Disorders during MMT; (5) Treatment of violence during MMT; (6) Treatment of Alcohol Use Disorder (AUD) during MMT. In treating Mood Disorder in HUD patients, we must bear in mind the interactions (potentiation and side effects) between psychopharmacology, used substances and agonist opioid medications; the use of psychiatric medications as an anti-craving drug, and the possible use of agonist and antagonist opioid medications in treating the other mental disorders. In treating chronic psychosis in HUD patients, we must consider the potentiation and side effects of antipsychotic drugs consequent on HUD treatment, worsening addiction hypophoria and inducing a more severe reward deficiency syndrome (RDS) in hypophoric patients. Violence and AUD during MMT can benefit from adequate dosages of methadone and co-medication with Sodium gamma-hydroxybutyrate (GHB). The experience of our V.P. Dole DD-RG suggests the following: (a) DD is the new paradigm in neuroscience in deepening our understanding of mental health; (b) To successfully treat DD patients a double competence is needed; (c) In managing DD patients priority must be given to Substance Use Disorder (SUD) treatment (stabilizing patients); (d) Antidepressant use is ancillary to SUD treatment; antipsychotic use must be restricted to acute phases; mood stabilizers must be preferred; any use of Benzodiazepines (BDZs) must be avoided.
引用
收藏
页数:26
相关论文
共 208 条